NMDA receptor and neonatal hypoxic brain injury
✍ Scribed by Mishra, Om P. ;Fritz, Karen I. ;Delivoria-Papadopoulos, Maria
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 137 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1080-4013
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The NMDA‐type glutamate receptor is a predominant mediator of excitotoxicity in the immature brain due to overexpression of the receptor in the developing brain. Within the development period however, the extent of NMDA receptor mediated processes including hypoxia‐induced excitotoxicity may depend on the ontogeny of the NMDA receptor recognition and modulation sites, and subunits leading to altered function of the ion‐channel comples. The function of the receptor may be modified by intracellular mechanisms such as phosphorylation/dephosphorylation, nitration, and generation of free radicals including nitric oxide. The susceptibility of the developing brain to hypoxia depends on several factors: the lipid composition of the brain cell membrane; the rate of membrane lipid peroxidation and the status of anti‐oxidant defenses; the development and modulation of the NMDA receptor sites; the intracellular Ca^2+^ influx mechanisms; expression of apoptotic and antiapoptotic genes such as Bax and Bcl‐2; and the activation of initiator caspases and caspase‐3, the “executioner” of cell death. The developmental status of these cellular mechanisms and their response to hypoxia determine the fate of the hypoxic cell in the developing brain in the fetus and the newborn. MRDD Research Reviews 2001;7:249–253. © 2001 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Hypoxic-ischemic brain injury in the perinatal period is a major cause of morbidity and mortality. Presently, there are no proven effective therapies with which to safeguard the human neonatal brain against this type of injury. Minocycline, a semisynthetic tetracycline, has been shown to be neuropro
## Abstract Neonatal hypoxic‐ischemic (HI) white matter injury is a major contributor to chronic neurological dysfunction. Immature oligodendrocytes (OLGs) are highly vulnerable to HI injury. As little is known about in vivo OLG repair mechanisms in neonates, we studied whether new OLGs are generat
## Abstract Minocycline is a second‐generation tetracycline and a potential neuroprotective intervention following brain injury. However, despite the recognized beneficial effects of minocycline in a multitude of adult disease states, the clinical application of minocycline in neonates is contentio